Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

<p>Fragments for the development of ATAD2 bromodomain inhibitors have been identified and characterized by NMR and co-crystallization.</p>

Original publication

DOI

10.1039/c4md00237g

Type

Journal article

Journal

Med. Chem. Commun.

Publisher

Royal Society of Chemistry (RSC)

Publication Date

01/12/2014

Volume

5

Pages

1843 - 1848